Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rinaldo

Showing results (271-280 of 324) with videos related to

Pageof 33
Sort By:
Nature Communications|November 20, 2025
A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infectionF Fouladi, Y Chen, S Bera, et al.
Journal of Virology|March 9, 2002
Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccineDeborah Heydenburg Fuller, Premeela A Rajakumar, Lawrence A Wilson, et al.
Journal of Leukocyte Biology|August 31, 2024
Attenuation of HIV-specific T cell responses Among people with HIV on ART following dipyridamole treatmentBenjamin C Morris, Emily A Hixson, Cynthia Klamar-Blain, et al.
Open Forum Infectious Diseases|March 12, 2020
Oral Cytokine Levels Are More Linked to Levels of Plasma and Oral HIV-1 RNA Than to CD4<sup>+</sup> T-Cell Counts in People With HIVJoseph M Rocco, Zachary York, Chengli Shen, et al.
The Journal of Infectious Diseases|July 9, 2019
A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic InflammationBernard J C Macatangay, Edwin K Jackson, Kaleab Z Abebe, et al.
Journal of Virology|February 7, 2001
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiencyC R Rinaldo, X L Huang, Z Fan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infectionJanis V Giorgi, Robert H Lyles, Jose L Matud, et al.
Journal of Clinical Microbiology|July 16, 1999
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasmaL M Kirstein, J W Mellors, C R Rinaldo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 29, 2025
Identifying Metabolomic Biomarkers of Lung Function Decline in People with HIVTyler C Lovelace, Stacy L Gelhaus, Barbara Methé, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2011
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphomaElizabeth Crabb Breen, Shehnaz K Hussain, Larry Magpantay, et al.
Pageof 33

Showing results (271-280 of 324) with videos related to

Sort By:
Pageof 33
Nature Communications|November 20, 2025
A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infectionF Fouladi, Y Chen, S Bera, et al.
Journal of Virology|March 9, 2002
Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccineDeborah Heydenburg Fuller, Premeela A Rajakumar, Lawrence A Wilson, et al.
Journal of Leukocyte Biology|August 31, 2024
Attenuation of HIV-specific T cell responses Among people with HIV on ART following dipyridamole treatmentBenjamin C Morris, Emily A Hixson, Cynthia Klamar-Blain, et al.
Open Forum Infectious Diseases|March 12, 2020
Oral Cytokine Levels Are More Linked to Levels of Plasma and Oral HIV-1 RNA Than to CD4<sup>+</sup> T-Cell Counts in People With HIVJoseph M Rocco, Zachary York, Chengli Shen, et al.
The Journal of Infectious Diseases|July 9, 2019
A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic InflammationBernard J C Macatangay, Edwin K Jackson, Kaleab Z Abebe, et al.
Journal of Virology|February 7, 2001
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiencyC R Rinaldo, X L Huang, Z Fan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infectionJanis V Giorgi, Robert H Lyles, Jose L Matud, et al.
Journal of Clinical Microbiology|July 16, 1999
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasmaL M Kirstein, J W Mellors, C R Rinaldo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 29, 2025
Identifying Metabolomic Biomarkers of Lung Function Decline in People with HIVTyler C Lovelace, Stacy L Gelhaus, Barbara Methé, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2011
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphomaElizabeth Crabb Breen, Shehnaz K Hussain, Larry Magpantay, et al.
Pageof 33